← All drugs Report issue

MDX-H210

mAbexperimentalBi-specific

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

High affinity immunoglobulin gamma Fc receptor IBINDING AGENT
FCGR1A binding agent
- High affinity immunoglobulin gamma Fc receptor I (FCGR1A) ↗
Receptor protein-tyrosine kinase erbB-2BINDING AGENT
ERBB2 binding agent
- Receptor tyrosine-protein kinase erbB-2 (ERBB2) ↗

Chemistry & pharmacology

Multi-specific: Yes (Bi-specific)

Oral

No

Parenteral

No

Topical

No